A Thrombin-Activated PAR-1 Pathway Drives Pancreatic Ductal Adenocarcinoma (PDAC) Growth and Metastasis

Journal of Purdue Undergraduate Research
doi 10.5703/1288284316964
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Purdue University Press

Related search

Overexpression of Mesothelin in Pancreatic Ductal Adenocarcinoma (PDAC)

International Journal of Medical Sciences
Medicine
2020English

MSP-RON Signaling Is Activated in the Transition From Pancreatic Intraepithelial Neoplasia (PanIN) to Pancreatic Ductal Adenocarcinoma (PDAC)

Frontiers in Physiology
Physiology
2019English

Metastasis in Pancreatic Ductal Adenocarcinoma: Current Standing and Methodologies

Genes
Genetics
2019English

TRAIL Promotes Metastasis of Human Pancreatic Ductal Adenocarcinoma

Oncogene
Cancer ResearchGeneticsMolecular Biology
2006English

Genomic and Transcriptomic Characterization of Advanced Pancreatic Ductal Adenocarcinoma (PDAC) May Inform Systemic Therapy

HPB
HepatologyGastroenterology
2017English

Fibroblast Activation Protein Augments Progression and Metastasis of Pancreatic Ductal Adenocarcinoma

JCI insight
Medicine
2017English

Pancreatic Ductal Adenocarcinoma inBRCA2mutation Carriers: Table 1

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2016English

TP63-Mediated Enhancer Reprogramming Drives the Squamous Subtype of Pancreatic Ductal Adenocarcinoma

Cell Reports
BiochemistryGeneticsMolecular Biology
2018English

Immunohistochemical Expression of NEDD9, E-Cadherin and Γ-Catenin and Their Prognostic Significance in Pancreatic Ductal Adenocarcinoma (PDAC)

Bosnian Journal of Basic Medical Sciences
Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy